ATC Group: A02BX13 Alginic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BX13 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
5
A02BX13
Alginic acid

Active ingredients in A02BX13

Active Ingredient
Description

Alginic acid is a polysaccharide distributed widely in the cell walls of brown algae which is hydrophilic and forms a viscous gum when hydrated. Its salts with metals such as sodium and calcium are known as alginates. It is a significant component of the biofilms produced by the bacterium Pseudomonas aeruginosa, a major pathogen found in the lungs of some people who have cystic fibrosis. The biofilm and P. aeruginosa have a high resistance to antibiotics and are susceptible to inhibition by macrophages.

Medicines in this ATC group

Drug
Countries

United Kingdom

South Africa

Turkey

Finland

Turkey

Austria Cyprus Ecuador France Hong Kong ...

New Zealand Turkey United Kingdom

Cyprus France

United Kingdom

Turkey

Turkey